These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 2846658

  • 1. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome.
    Anderson S, Diamond JR, Karnovsky MJ, Brenner BM.
    J Clin Invest; 1988 Nov; 82(5):1757-68. PubMed ID: 2846658
    [Abstract] [Full Text] [Related]

  • 2. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
    Diamond JR, Anderson S.
    Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
    [Abstract] [Full Text] [Related]

  • 3. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
    Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I.
    J Clin Invest; 1988 Jul; 82(1):322-30. PubMed ID: 3392211
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G.
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S, Rennke HG, Brenner BM.
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.
    Anderson S, Meyer TW, Rennke HG, Brenner BM.
    J Clin Invest; 1985 Aug; 76(2):612-9. PubMed ID: 2993362
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.
    Glasser RJ, Velosa JA, Michael AF.
    Lab Invest; 1977 May; 36(5):519-26. PubMed ID: 865079
    [Abstract] [Full Text] [Related]

  • 10. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J, Weening JJ, Elema JD.
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [Abstract] [Full Text] [Related]

  • 11. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR, Mauer SM, Michael AF.
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [Abstract] [Full Text] [Related]

  • 12. Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.
    Adamczak M, Gross ML, Amann K, Ritz E.
    J Am Soc Nephrol; 2004 Dec; 15(12):3063-72. PubMed ID: 15579509
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A.
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [Abstract] [Full Text] [Related]

  • 14. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T, Yamakage K, Kurosawa K, Kyogoku Y, Furuyama T, Yoshinaga K.
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [Abstract] [Full Text] [Related]

  • 15. Focal glomerular sclerosis in aminonucleoside nephropathy.
    Saito T, Furuyama T, Kyogoku Y, Yamakage K, Arakawa M, Yoshinaga K.
    Tohoku J Exp Med; 1981 Mar; 133(3):349-60. PubMed ID: 6171910
    [No Abstract] [Full Text] [Related]

  • 16. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury.
    Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM.
    Kidney Int; 1994 Aug; 46(2):396-404. PubMed ID: 7967351
    [Abstract] [Full Text] [Related]

  • 17. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Aug; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 18. Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria.
    Howie AJ, Kizaki T, Beaman M, Morland CM, Birtwistle RJ, Adu D, Michael J, Williams AJ, Walls J, Matsuyama M.
    J Pathol; 1989 Feb; 157(2):141-51. PubMed ID: 2921674
    [Abstract] [Full Text] [Related]

  • 19. [Glomerular kidney diseases that are associated with a large clinical proteinuria and/or nephrotic syndrome].
    Danilewicz M.
    Pol J Pathol; 2011 Jun; 62(2 Suppl 1):s32-40. PubMed ID: 23120829
    [No Abstract] [Full Text] [Related]

  • 20. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL, Rennke HG, Brenner BM, Anderson S.
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.